logo
How an Aberdeen family is changing the odds of cystic fibrosis in daughter's memory

How an Aberdeen family is changing the odds of cystic fibrosis in daughter's memory

Chloe Baxter was fiercely independent and loved nothing more than a good joke and loud music.
She had pink streaks in her hair, piercings in her lip and tongue and a talent for making people laugh — especially her dad, Tom.
'She had a wicked sense of humour,' says Tom, a former chemical engineer who lives in Aberdeen. 'And she was a big music fan. Everything from garage and grunge, Red Hot Chili Peppers and all that.'
Chloe died in 2006, aged just 23 and weeks after landing a new job she was thrilled about.
Battling cystic fibrosis since she was an infant, a chest infection took hold and, despite hospital treatment, she never recovered.
'At first we didn't expect the worst,' Tom says. 'But then I had that feeling — this was it.'
Diagnosed at 18 months old, Chloe faced long odds from the start.
'She had a 75% chance of reaching 16,' Tom remembers. 'She didn't know there was anything wrong with her at first. Later, she understood it was serious — but she just got on with it.'
Chloe studied English Literature at the University of Aberdeen and, despite repeated hospital stays, graduated with an upper second.
She worked as a care worker for disadvantaged adults, often taking night shifts where she was the only one on duty.
'She was determined,' Tom says. 'She wanted her independence, she left home at 18 and shared a flat with a friend.'
'We had a normal family life,' Tom adds. 'We'd get the CF out the way and carry on. When she wasn't infected, we'd go to France on holiday and have a good time.'
Chloe had just secured a new job preparing proposals at an engineering company — the same one where her mum, Grace, worked — when she became ill.
'She always wanted to do English at university,' Tom says. 'She had a really inspirational teacher who encouraged her.'
Like many with CF, Chloe faced complications. At 16, she developed diabetes.
'She was painfully thin,' Tom recalls. 'But once we got the diabetes under control, she put on some weight and had a lot more energy.'
There were joyful times too. 'We watched a lot of comedy — Bottom, The Young Ones, Monty Python — and laughed a lot.'
Ten years after Chloe's death, Tom and Grace set up a research fund in her memory at the University of Aberdeen.
'We had enough money to fund something for three years,' Tom explains. 'We chose to support research into how fungal infections interact with bacterial ones in CF.'
The project, called Chloe's Fund, struck a chord because Chloe had struggled with infections that wouldn't clear. The research is now on its third PhD student and has led to several academic papers.
'Each time, there have been significant findings,' Tom says. 'It gives us a lot of pleasure.'
The fund was created with the help of Chloe's CF consultant and Kairen Griffiths, a CF nurse at ARI whom Chloe was very close to. Kairen has even written a book on CF titled 65 Roses — the term young children often use when trying to say 'cystic fibrosis' — that includes Chloe.
'There's a chapter in the book based on Chloe,' Tom says. 'They don't use her name, but it's her story.'
Since Chloe passed away, there has been enormous progress in CF treatment. Drugs like Kaftrio, which target the root genetic cause of the disease, have dramatically increased life expectancy.
Tom says Chloe probably would have benefitted from the new genetic drugs, but he and Grace tend not to think about the what-ifs and maybes.
'It would torture you,' he says.
Meanwhile, they are delighted for the families that do benefit from it. 'There's no bitterness,' he says. 'We think it is fantastic.'
Kaftrio won't help everyone with CF — it depends on their genetic strain — but for those who can take it, the impact is dramatic.
'We used to be told CF couldn't be cured — that we could only treat the symptoms,' Tom says. 'Now, they've developed treatments that address the underlying cause.'
The odds in a CF patient's favour have improved significantly; instead of a 75% chance of making it to 16, it's now a 75% chance of reaching 60.
'That's phenomenal,' Tom says.
Chloe's presence is still very much felt in the Baxter family. Her younger sister, Gemma, now 38, has two young children. One has Chloe as a middle name.
They still talk about her, and she still surprises them.
When a film crew from the Cystic Fibrosis Trust came to hear their story recently, 'Gemma said a few things about her sister we'd never heard before,' Tom says.
Meanwhile, Tom and Grace still find comfort in remembering the good times. 'We can often talk about the laughs we had,' Tom says. 'It's made me a better person. You re-evaluate what's important.'
What would Chloe make of the fund and the work being done in her name?
'She'd love it. She'd be the poster girl.'
And for families living with CF today?
'Enjoy the new freedom you've got,' Tom says. 'And be forever thankful to medical science.'
Tom and Grace are working with the Cystic Fibrosis Trust to help raise money and awareness for Chloe's Fund at Aberdeen University.
To help Cystic Fibrosis Trust fund more important work, click here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

University makes 'ground-breaking' discovery offering hope for chronic pain sufferers
University makes 'ground-breaking' discovery offering hope for chronic pain sufferers

STV News

timea day ago

  • STV News

University makes 'ground-breaking' discovery offering hope for chronic pain sufferers

Scientists in Aberdeen have made a ground-breaking discovery that could revolutionise treatment for chronic pain. Researchers from the University of Aberdeen, Academia Sinica in Taiwan and a group of international experts have discovered that chronic and acute pain are physiologically different. It is hoped the breakthrough will lead to new treatments for conditions such as fibromyalgia and rheumatoid arthritis. Marlene Lowe knows only too well what it's like living with debilitating pain. The 35-year-old suffers from both chronic fatigue and fibromyalgia, which causes widespread pain. Often dismissed by the healthcare system, she says these conditions can feel like an invisible burden. STV News Marlene describes her experience of living with the chronic pain condition fibromyalgia She told STV News: 'One day you can be perfectly fine and you can go for a jog and the next day it is difficult to get out of bed. It's hard to balance those things out, so when you are in that state, people don't see you. 'They see you when you are feeling better and out and about. It's incredibly demoralising to say 'look, I'm in agonising pain constantly' and someone says 'But you are still working, you must be alright'.' Marlene is one of millions who suffer from persistent chronic pain which, unlike acute pain – typically caused by injury – is very hard to treat. Until now, Western cultures have not differentiated between the two. But scientists at Aberdeen University, together with experts from Taiwan, have discovered that in the nervous system, chronic pain is processed differently from the pain that comes from an injury or over exertion. Crucially, they found a new and distinct separate physiological pathway for this chronic type of pain, which means it can now be a target for future therapies. Dr Guy Bewick is a senior lecturer in biomedical science at the University of Aberdeen. 'The GP cannot give these patients anything to relieve the pain. It doesn't respond to painkillers,' he said. 'They have to give them moral support and advise them on things they should or shouldn't do, which will make it worse or better. 'But we think we have found the pathway. We have a model and we have found out how that gets turned on by two specific set of nerves, which are talking to each other.' STV News Dr Guy Bewick He explained that Eastern cultures have differentiated pain for centuries, with chronic pain being called 'sng' or 'suan tong' (sour pain) in Mandarin. 'The stinging pain from sharp objects and surgery can usually be treated effectively with common painkillers, but chronic pain often cannot,' he added. 'New treatments require an identifiably different drug target. This study has found that target. Specifically, we discovered the mechanism of this pain we call 'sng'.' Dr Bewick's team discovered that a molecule called glutamate is released in muscles to activate a highly unusual receptor. This sparked a collaboration with Professor Chen's team in Taiwan who found that too much glutamate release activated pain nerves nearby making them permanently active and not switch off as they normally would. Crucially, they then discovered that blocking the newly discovered, highly unusual, glutamate receptor entirely stopped the chronic pain being triggered. STV News Chronic pain has been shown to be physiologically different from acute pain – and now scientists have the roadmap for how to target it Scientists hope their findings will help develop new treatments for conditions such as fibromyalgia and rheumatoid arthritis. 'It's this ache which can become chronic and very distressing to some people,' Dr Bewick said. 'The acute pain responds well to painkillers; whereas the second pathway, people didn't know what it was. 'This has the potential to help the many people whose pain is currently inadequately treated.' The wider research was led by Professor Chih-Cheng Chen from Academia Sinica, supported by National Science and Technology Council's Brain Technology Project and an Investigator Award of Academia Sinica. They were able to differentiate between the two types of pain by genetically silencing neuronal pathways in a mouse model. At the Taipei Medical University Hospital in Taiwan, the theory was then tested in practice in a patient with a spinal cord injury that blocked 'standard' pain but spared the newly discovered pathway. Professor Chen said: 'Fundamentally, we found that sng persists even in people who have lost other pain sensation, for example, a patient with spinal cord damage did not notice when he had broken a toe but could still perceive 'sng' and position in the same leg. 'Clearly, therefore, sng is a separate pathway. 'This finding could lead to new pain relief treatments for such conditions as fibromyalgia, exercise-induced muscle pain (DOMS), rheumatoid arthritis, and chronic pain after spinal surgery. 'It is a truly ground-breaking discovery in pain research.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country

I've lost 3.8 stone on Mounjaro – I've had bad hair loss & another VERY unexpected side effect I'm not coping well with
I've lost 3.8 stone on Mounjaro – I've had bad hair loss & another VERY unexpected side effect I'm not coping well with

Scottish Sun

time2 days ago

  • Scottish Sun

I've lost 3.8 stone on Mounjaro – I've had bad hair loss & another VERY unexpected side effect I'm not coping well with

A MOTHER has revealed that despite losing over three stone thanks to Mounjaro, she has been hit with some unfortunate side effects. Chloe Mckernan, 32, a mum-of-two from Glasgow who is currently on her 'glow up journey', got candid on the side effects, which are not limited to hair loss. 4 A mum-of-two has explained that in addition to hair loss, she has experienced a very unexpected side effect since using Mounjaro Credit: TikTok/@chlo_mckernan 4 Chloe claimed that since using Mounjaro, her new hairs have been growing in GREY Credit: TikTok/@chlo_mckernan 4 Mounjaro is typically used to treat type 2 diabetes Credit: Getty The brunette, who recently opened up on dealing with a sore scalp and a strange 'burning sensation', has now got candid on the unexpected implication that she is 'not coping' well with. Posting on social media, Chloe, who has the 'confidence to wear shorts again', revealed that she has lost 3 stone 8 lbs since using Mounjaro. The young woman confirmed that as a result of taking Mounjaro, which is regarded by some as the King Kong of weight loss jabs, she has been accused of 'cheating' her weight loss. Sun GP Dr Zoe Williams claimed that Mounjaro, which could soon be rolled out on the NHS, can save the lives of people with 'life-threatening levels of obesity'. But despite this, the NHS warned: 'Never take an anti-obesity medicine if it has not been prescribed to you. "These types of medicines may not be safe for you and can cause serious side effects.' In recent clips shared online, Chloe discussed the side effects she has experienced since taking Mounjaro. As she held a huge pile of hair extensions, which she claimed have fallen out of her head since using the jabs, she said: 'These [extensions] have all come out my head. 'I'm actually really scared to get my hair done on Thursday because I don't know how much of my actual hair I've got left. I'm actually so scared.' As she showed off her natural hair underneath her extensions, she added: 'My hair has been really bad. I don't have much hair underneath, my hair is getting really thin.' Weight Loss Jabs - Pros vs Cons While hair loss isn't a direct side effect listed in Mounjaro's package insert, a 2022 clinical trial showed that 4.9% to 5.7% of participants taking Mounjaro reported hair loss, compared to 0.9% in the placebo group, Drugs reported. This is usually a result of a rapid weight loss. Not only this, but in another clip which was uploaded with the caption 'Mounjaro girls…anyone else's hair growing back in grey after hair loss?', Chloe claimed that since using the fat jabs, any new hairs that have grown have been grey - yes, you heard that correctly. All the new hairs are growing in white, I can't be dealing with that Chloe Mckernan The mother said: 'So obviously I've had hair loss on Monjaro, but I'm not coping with the grey hairs that are poking through my head. 'I'm 32 not 62, why have I get grey hairs? All the new hairs are growing in white, I can't be dealing with that.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Despite Chloe's concerns, there is currently no scientific evidence directly linking Mounjaro to an increase in grey hair. However, some individuals, including Chloe, have reported changes in their hair colour or texture whilst taking fat jabs. It appears that these observations may be influenced by factors such as diet, nutritional intake, and overall health. Social media users react Chloe's TikTok clip, which was posted under the username @chlo_mckernan, has clearly left many open-mouthed, as it has quickly racked up 165,200 views, 636 likes and 115 comments. Numerous other Mounjaro users eagerly flocked to the comments, keen to express that they too have experienced hair loss whilst using fat jabs. It's not Mounjaro!! It's the weight loss, it will grow back TikTok user One person said: 'My hair has fallen out so much since being on Mounjaro.' Another added: 'My hair was falling out in CHUNKS, it's so scary.' A third commented: 'I've had the longest and thickest hair for years and I've lost so much hair.' Hair Loss 101 HAIR pro Samantha Cusick has revealed everything you need to know about hair loss. Why Does Hair Loss Happen? Hair loss can be influenced by so many factors, from genetics and hormone changes to lifestyle choices. Stress, diet, and even hair care habits can all impact hair strength. It's perfectly normal to lose some hair each day, but sometimes the body can shed more than usual, responding to things like hormonal shifts or even life stressors. Why It Happens More This Time of Year Have you ever noticed your hair seems to shed more in autumn? That's seasonal shedding! During summer, we hold onto extra hair to protect our scalp from the sun. As the weather cools, it's like our body recalibrates and lets go of those extra strands. Dry, cooler air can also make hair more brittle, making it easier to lose a little extra volume during these months. Hacks and Affordable Buys to Treat Hair loss The great news? You don't need to spend a fortune on pricey treatments to support your hair. Try daily scalp massages—they're so simple but really help boost blood flow to the follicles. Castor oil is another fantastic, budget-friendly option that's rich in nutrients to strengthen your strands. Adding a bit more protein to your diet and a biotin supplement can also work wonders for overall hair health. Products to Avoid Steer clear of products with high levels of alcohol, sulphates, and parabens - they can be drying and damage hair over time. Heat styling and chemical treatments can also cause breakage, so try to use them sparingly. Instead, look for gentle, hydrating formulas to support your scalp and keep hair healthier through the seasons. But at the same time, one user clarified: 'It's not Mounjaro!! It's the weight loss, it will grow back.' Meanwhile, another agreed: 'Hair loss means you aren't eating enough. 'It's important to get enough calories in, otherwise you're doing as much damage as good.' Fatal consequences In addition to hair loss, those debating whether to begin using Mounjaro should know that the jabs can have fatal consequences. The injections are licensed for patients with type 2 diabetes and are administered every seven days. 4 They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over). The drugs can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber. But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks. Not only this, but figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK. Following the death of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, his family are now calling for a probe into the jab's "potential to kill." Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club

Aspiring dentist who fled Taliban builds new life in Glasgow
Aspiring dentist who fled Taliban builds new life in Glasgow

Glasgow Times

time3 days ago

  • Glasgow Times

Aspiring dentist who fled Taliban builds new life in Glasgow

Shakiba Azim, who left her home country four years ago, is now working towards her dream career by volunteering at NHS Golden Jubilee. She said: "When I came here, I realised I finally had the freedom and the right to follow my dream." 'Back in Afghanistan, I was offered a place at university to study dentistry, but it was too far from home and, as a girl without a male relative, I wasn't allowed to go." "Volunteering at NHS Golden Jubilee has been my way of starting again and working towards that goal.' In 2021, Shakiba was working as a journalist. This placed her family at significant risk when the Taliban came back to power. They fled the country for Pakistan before applying for a humanitarian visa to the UK, eventually settling in Glasgow. She said: "I lost everything overnight. "Because of my job, my family and I were at risk. "We escaped to Pakistan and applied for a visa. "After two years, we arrived in the UK." "I remember Googling it and being nervous about the Scottish accent, but when we got here, we found the people so kind and helpful. "I fell in love with Scotland." Shakiba is now building a new future in the country she calls home, where she lives with her mother and younger sister. Her sister is also an outpatient support volunteer in the radiology department at NHS Golden Jubilee. Both are completing English language courses to help them begin their next step into higher education. In a few weeks, they will move on to new science-based courses at college. Shakiba said: "We're working hard to build our future. 'Volunteering has been a great experience. "Everyone has been so supportive and kind. "I'm so grateful to be part of this team. "Volunteering here has helped me develop skills, build my confidence, and understand how healthcare works in Scotland. "It's also shown me how much I enjoy helping people.' "This country gave me a second chance. "I want to stay here and give something back.' As part of Volunteer Week 2025, NHS Golden Jubilee is recognising the contributions of its volunteers. The NHS board, which has 50 volunteers in various patient care support roles, has signed Volunteers Scotland Volunteer Charter. It is committed to being a Volunteer Charter Champion to recognise and celebrate the dedication of its volunteers. NHS Golden Jubilee has signed the Volunteers in Scotland Volunteer Charter to commit to celebrating its volunteers (Image: NHS Golden Jubilee) Maureen Franks, volunteer manager, said: "Volunteers like Shakiba are at the heart of our volunteering community. "Her story is inspiring, showing the power of resilience, and we are proud to support her journey and are lucky to have her as part of Team Jubilee. Tosh Lynch, head of Spiritual Care and Volunteer Services, said: 'As an organisation, we understand that our volunteers support us to enhance the patient and visitor experience through a variety of services such as Pastoral Care and Patient Peer Support. 'By providing quality, safe, effective, and person-centred care our volunteers play an important role in enhancing the hospital experience for every patient or visitor and in shaping future services.' More information on how to become a volunteer at NHS Golden Jubilee can be found on the hospital's website.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store